223 related articles for article (PubMed ID: 30098167)
21. The incidence of central serous chorioretinopathy in Olmsted County, Minnesota, 1980-2002.
Kitzmann AS; Pulido JS; Diehl NN; Hodge DO; Burke JP
Ophthalmology; 2008 Jan; 115(1):169-73. PubMed ID: 18166410
[TBL] [Abstract][Full Text] [Related]
22. The Correlation of Central Serous Chorioretinopathy and Subsequent Cardiovascular Diseases of Different Types: A Population-Based Cohort Study.
Hsu HJ; Lee CY; Chao SC; Nien CW; Tzeng SH; Huang JY; Ko TC; Yang SF; Lin HY
Int J Environ Res Public Health; 2019 Dec; 16(24):. PubMed ID: 31847232
[TBL] [Abstract][Full Text] [Related]
23. Central Serous Chorioretinopathy in a 14-year-old atopic boy: a case report.
Ranno S; Fontanel L; Ruggiero E; Nucci P; Radice P; Donati S
Ital J Pediatr; 2023 Jan; 49(1):1. PubMed ID: 36597009
[TBL] [Abstract][Full Text] [Related]
24. Increased risk for central serous chorioretinopathy in nephrotic syndrome patients: A population-based cohort study.
Lee LC; Wu TJ; Huang KH; Chen YH; Chen JT; Chung CH; Chien WC; Chen CL
J Chin Med Assoc; 2021 Nov; 84(11):1060-1069. PubMed ID: 34320516
[TBL] [Abstract][Full Text] [Related]
25. Intranasal Corticosteroids and Central Serous Chorioretinopathy: A Report and Review of the Literature.
Nakatsuka AS; Khanamiri HN; Lam QN; El-Annan J
Hawaii J Med Public Health; 2019 May; 78(5):151-154. PubMed ID: 31049263
[TBL] [Abstract][Full Text] [Related]
26. RISK OF RETINAL VEIN OCCLUSION WITH CENTRAL SEROUS CHORIORETINOPATHY.
Chang YS; Chang C; Weng SF; Wang JJ; Jan RL
Retina; 2016 Apr; 36(4):798-804. PubMed ID: 26441266
[TBL] [Abstract][Full Text] [Related]
27. Central serous chorioretinopathy associated with inhaled or intranasal corticosteroids.
Haimovici R; Gragoudas ES; Duker JS; Sjaarda RN; Eliott D
Ophthalmology; 1997 Oct; 104(10):1653-60. PubMed ID: 9331207
[TBL] [Abstract][Full Text] [Related]
28. RISK OF RHEGMATOGENOUS RETINAL DETACHMENT WITH CENTRAL SEROUS CHORIORETINOPATHY.
Chang YS; Chang C; Weng SF; Wang JJ; Jan RL
Retina; 2016 Aug; 36(8):1446-53. PubMed ID: 26716956
[TBL] [Abstract][Full Text] [Related]
29. Central serous chorioretinopathy secondary to corticosteroids in patients with atopic disease.
Ricketti PA; Unkle DW; Cleri DJ; Prenner JL; Coluccielo M; Ricketti AJ
Allergy Asthma Proc; 2015; 36(2):123-9. PubMed ID: 25715240
[TBL] [Abstract][Full Text] [Related]
30. CHOROIDAL THICKNESS OF CENTRAL SEROUS CHORIORETINOPATHY SECONDARY TO CORTICOSTEROID USE.
Honda S; Miki A; Kusuhara S; Imai H; Nakamura M
Retina; 2017 Aug; 37(8):1562-1567. PubMed ID: 27787451
[TBL] [Abstract][Full Text] [Related]
31. Central serous chorioretinopathy associated with topical corticosteroids in a patient with psoriasis.
Ezra N; Taban M; Behroozan D
J Drugs Dermatol; 2011 Aug; 10(8):918-21. PubMed ID: 21818516
[TBL] [Abstract][Full Text] [Related]
32. Central serous chorioretinopathy and phosphodiesterase-5 inhibitors: a case-control postmarketing surveillance study.
French DD; Margo CE
Retina; 2010 Feb; 30(2):271-4. PubMed ID: 20010456
[TBL] [Abstract][Full Text] [Related]
33. Use of inhaled and oral corticosteroids and the long-term risk of cataract.
Wang JJ; Rochtchina E; Tan AG; Cumming RG; Leeder SR; Mitchell P
Ophthalmology; 2009 Apr; 116(4):652-7. PubMed ID: 19243828
[TBL] [Abstract][Full Text] [Related]
34. Central serous chorioretinopathy and risk of ischaemic stroke: a population-based cohort study.
Tsai DC; Huang CC; Chen SJ; Chou P; Chung CM; Chan WL; Huang PH; Chen TJ; Lin SJ; Chen JW; Leu HB
Br J Ophthalmol; 2012 Dec; 96(12):1484-8. PubMed ID: 22976583
[TBL] [Abstract][Full Text] [Related]
35. Association of Physical Activity Level With Risk of Dementia in a Nationwide Cohort in Korea.
Yoon M; Yang PS; Jin MN; Yu HT; Kim TH; Jang E; Uhm JS; Pak HN; Lee MH; Joung B
JAMA Netw Open; 2021 Dec; 4(12):e2138526. PubMed ID: 34913979
[TBL] [Abstract][Full Text] [Related]
36. Efficacy of photodynamic therapy in steroid-associated chronic central serous chorioretinopathy: a case-control study.
Breukink MB; Mohabati D; van Dijk EH; den Hollander AI; de Jong EK; Dijkman G; Keunen JE; Hoyng CB; Boon CJ
Acta Ophthalmol; 2016 Sep; 94(6):565-72. PubMed ID: 27149889
[TBL] [Abstract][Full Text] [Related]
37. Choroidal thickness evaluation of healthy eyes, central serous chorioretinopathy, and fellow eyes using spectral domain optical coherence tomography in Indian population.
Arora S; Pyare R; Sridharan P; Arora T; Thakar M; Ghosh B
Indian J Ophthalmol; 2016 Oct; 64(10):747-751. PubMed ID: 27905337
[TBL] [Abstract][Full Text] [Related]
38. Central serous chorioretinopathy, corticosteroids, and uveitis.
Khairallah M; Kahloun R; Tugal-Tutkun I
Ocul Immunol Inflamm; 2012 Apr; 20(2):76-85. PubMed ID: 22409559
[TBL] [Abstract][Full Text] [Related]
39. Risk of retinopathy in women with pregnancy-induced hypertension: a nationwide population-based cohort study of 9-year follow-up after delivery.
Lee H; Yang SW; Kim Y; Shin H; Seo YS; Oh MJ; Choi S; Cho GJ; Hwang HS
Am J Obstet Gynecol MFM; 2023 Jul; 5(7):100985. PubMed ID: 37119970
[TBL] [Abstract][Full Text] [Related]
40. Clinical evaluation of neovascular and non-neovascular chronic central serous chorioretinopathy (CSC) diagnosed by swept source optical coherence tomography angiography (SS OCTA).
Sulzbacher F; Schütze C; Burgmüller M; Vécsei-Marlovits PV; Weingessel B
Graefes Arch Clin Exp Ophthalmol; 2019 Aug; 257(8):1581-1590. PubMed ID: 31037488
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
